Larimar Therapeutics, Inc. (LRMR) has 12 identified peers for comparison in the Healthcare sector. Peers include ALEC, BOLT, CABA, CELC, CHRS, CNTA and others.
LRMR has a market capitalization of $416.77M, compared to an average peer market cap of $1.36B. LRMR is notably smaller than its average peer.